13F-HR filed by JOHNSON & JOHNSON
JOHNSON & JOHNSON filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-07-22, with 20 holding rows worth $334,096,397.
- Accession
- 0000904454-25-000367
- Filer
- CIK 200406
- Filed
- 2025-07-22
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 20 entries on the cover page, a total value of $334,096,397 stated on the cover page (in dollars after the unit check, H1), rows summing to $334,096,397 with VALUE read as dollars as filed, 13F file number 028-20072. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJohnson & Johnson Innovation - JJDC, Inc.028-20073
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 2,449,183 | $136,395,001 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 6,641,064 | $43,897,433 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 2,498,051 | $28,552,723 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 814,586 | $28,209,113 | dollars as filed | |
| NANOBIOTIX | 63009J107 | SPONSORED ADS | 5,623,816 | $25,454,516 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 4,103,430 | $23,881,963 | dollars as filed | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 357,939 | $20,370,308 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 1,979,173 | $8,134,401 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 748,062 | $6,089,225 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 247,598 | $3,981,376 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 3,379,064 | $3,514,227 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 1,849,445 | $1,399,845 | dollars as filed | |
| RALLYBIO CORP | 75120L100 | COM | 3,636,363 | $1,209,454 | dollars as filed | |
| VOR BIOPHARMA INC | 929033108 | COM | 1,074,658 | $1,139,137 | dollars as filed | |
| NANO X IMAGING LTD | M70700105 | ORD SHS | 158,852 | $830,796 | dollars as filed | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 311,967 | $371,241 | dollars as filed | |
| LYELL IMMUNOPHARMA INC | 55083R104 | COM | 41,165 | $368,015 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 364,472 | $228,014 | dollars as filed | |
| BIOMX INC | 09090D103 | COM | 96,866 | $42,621 | dollars as filed | |
| SENSEONICS HLDGS INC | 81727U105 | COM | 54,621 | $26,988 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000904454-25-000367 | this filing | 2025-07-22 | acceptance time not in the bulk data set |